xRead - September 2022

Wise et al.

Page 268

1698. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis based comparison. J Allergy Clin Immunol. 2012;130:1097–1107.e2. [PubMed: 23021885] 1699. Nelson H, Cartier S, Allen-Ramey F, Lawton S, Calderon MA. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy. J Allergy Clin Immunol Pract. 2015;3:256–266.e3. [PubMed: 25609326] 1700. Aasbjerg K, Dalhoff KP, Backer V. Adverse events during immunotherapy against grass pollen induced allergic rhinitis—differences between subcutaneous and sublingual treatment. Basic Clin Pharmacol Toxicol. 2015;117:73–84. [PubMed: 25968654] 1701. Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract. 2014;20:225–238. [PubMed: 24444390] 1702. Calderon MA, Casale TB, Nelson HS, Demoly P. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol. 2013;132:1322–1336. [PubMed: 24139829] 1703. Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013;131:1361–1366. [PubMed: 23557834] 1704. Hoeks SB, de Groot H, Hoekstra MO. [Sublingual immunotherapy in children with asthma or rhinoconjunctivitis: not enough evidence because of poor quality of the studies; a systematic review of literature]. Ned Tijdschr Geneeskd. 2008;152:261–268. Dutch. [PubMed: 18333541] 1705. Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129:717–725.e5. [PubMed: 22285278] 1706. Didier A, Malling HJ, Worm M, Horak F, Sussman GL. Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. Clin Transl Allergy. 2015;5:12. [PubMed: 26097680] 1707. Larsson O, Hellkvist L, Peterson-Westin U, Cardell LO. Novel strategies for the treatment of grass pollen-induced allergic rhinitis. Expert Opin Biol Ther. 2016;16:1143–1150. [PubMed: 27269991] 1708. Senti G, Kundig TM. Novel delivery routes for allergy immunotherapy: intralymphatic, epicutaneous, and intradermal. Immunol Allergy Clin North Am. 2016;36:25–37. [PubMed: 26617225] 1709. Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep. 2013;13:178–195. [PubMed: 23315329] 1710. Garaczi E, Szabo K, Francziszti L, et al. DermAll nanomedicine for allergen-specific immunotherapy. Nanomedicine. 2013;9:1245–1254. [PubMed: 23747740] 1711. Phillips EW. Relief of hay-fever by intradermal injections of pollen extract. JAMA. 1926;86:182–184. 10.1001/jama.1926.02670290022008. 1712. Senti G, Graf N, Haug S, et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol. 2009;124:997–1002. [PubMed: 19733905] 1713. Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy. 2010;65:410–411. [PubMed: 19804450] 1714. Senti G, von Moos S, Tay F, et al. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol. 2012;129:128–135. [PubMed: 21996342] 1715. Senti G, von Moos S, Tay F, Graf N, Johansen P, Kundig TM. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70:707–710. [PubMed: 25704072] 1716. Senti G, Prinz Vavricka BM, Erdmann I, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A. 2008;105:17908–17912. [PubMed: 19001265]

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.